Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression

Abstract Endothelium-dependent flow-mediated dilation (ED-FMD), a biophysical marker of endothelial dysfunction, is apparently impaired in patients with systemic lupus erythematosus (SLE) but such observation is inconsistent. Here, we assessed and compared the brachial artery ED-FMD (baED-FMD) using...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anselm Mak, Nien Yee Kow, Herbert Schwarz, Lingli Gong, Sen Hee Tay, Lieng Hsi Ling
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9f13af13966642c1ab0cbd75378c780d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9f13af13966642c1ab0cbd75378c780d
record_format dspace
spelling oai:doaj.org-article:9f13af13966642c1ab0cbd75378c780d2021-12-02T15:06:09ZEndothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression10.1038/s41598-017-07574-12045-2322https://doaj.org/article/9f13af13966642c1ab0cbd75378c780d2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07574-1https://doaj.org/toc/2045-2322Abstract Endothelium-dependent flow-mediated dilation (ED-FMD), a biophysical marker of endothelial dysfunction, is apparently impaired in patients with systemic lupus erythematosus (SLE) but such observation is inconsistent. Here, we assessed and compared the brachial artery ED-FMD (baED-FMD) using ultrasonography between SLE patients without cardiovascular disease and healthy controls (HC) matched for age, gender and body mass index. We then performed a comprehensive meta-analysis of case-control studies which compared baED-FMD between SLE patients and HC by determining the effect size of baED-FMD as standardized mean difference (SMD). Factors associated with the effect size were explored by mixed-model meta-regression. Seventy one SLE patients and 71 HC were studied. SLE patients had lower baED-FMD than HC (3.72 ± 2.8% vs 4.63 ± 3.1%, p = 0.032). Meta-analysis of 25 case-control studies involving 1,313 SLE patients and 1,012 HC with the random effects model revealed lower baED-FMD in SLE patients compared to HC (SMD −1.077, p < 0.001). The presence of diabetes mellitus (p = 0.04747), higher diastolic blood pressure (p = 0.044), renal involvement (p = 0.027) and aspirin use (p = 0.001) were associated with more discrepant baED-FMD between both groups. In conclusion, SLE patients naïve of cardiovascular disease have impaired endothelial function. Diabetes mellitus, renal disease and diastolic hypertension are major contributors of endothelial dysfunction in SLE patients.Anselm MakNien Yee KowHerbert SchwarzLingli GongSen Hee TayLieng Hsi LingNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Anselm Mak
Nien Yee Kow
Herbert Schwarz
Lingli Gong
Sen Hee Tay
Lieng Hsi Ling
Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
description Abstract Endothelium-dependent flow-mediated dilation (ED-FMD), a biophysical marker of endothelial dysfunction, is apparently impaired in patients with systemic lupus erythematosus (SLE) but such observation is inconsistent. Here, we assessed and compared the brachial artery ED-FMD (baED-FMD) using ultrasonography between SLE patients without cardiovascular disease and healthy controls (HC) matched for age, gender and body mass index. We then performed a comprehensive meta-analysis of case-control studies which compared baED-FMD between SLE patients and HC by determining the effect size of baED-FMD as standardized mean difference (SMD). Factors associated with the effect size were explored by mixed-model meta-regression. Seventy one SLE patients and 71 HC were studied. SLE patients had lower baED-FMD than HC (3.72 ± 2.8% vs 4.63 ± 3.1%, p = 0.032). Meta-analysis of 25 case-control studies involving 1,313 SLE patients and 1,012 HC with the random effects model revealed lower baED-FMD in SLE patients compared to HC (SMD −1.077, p < 0.001). The presence of diabetes mellitus (p = 0.04747), higher diastolic blood pressure (p = 0.044), renal involvement (p = 0.027) and aspirin use (p = 0.001) were associated with more discrepant baED-FMD between both groups. In conclusion, SLE patients naïve of cardiovascular disease have impaired endothelial function. Diabetes mellitus, renal disease and diastolic hypertension are major contributors of endothelial dysfunction in SLE patients.
format article
author Anselm Mak
Nien Yee Kow
Herbert Schwarz
Lingli Gong
Sen Hee Tay
Lieng Hsi Ling
author_facet Anselm Mak
Nien Yee Kow
Herbert Schwarz
Lingli Gong
Sen Hee Tay
Lieng Hsi Ling
author_sort Anselm Mak
title Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
title_short Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
title_full Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
title_fullStr Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
title_full_unstemmed Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
title_sort endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/9f13af13966642c1ab0cbd75378c780d
work_keys_str_mv AT anselmmak endothelialdysfunctioninsystemiclupuserythematosusacasecontrolstudyandanupdatedmetaanalysisandmetaregression
AT nienyeekow endothelialdysfunctioninsystemiclupuserythematosusacasecontrolstudyandanupdatedmetaanalysisandmetaregression
AT herbertschwarz endothelialdysfunctioninsystemiclupuserythematosusacasecontrolstudyandanupdatedmetaanalysisandmetaregression
AT lingligong endothelialdysfunctioninsystemiclupuserythematosusacasecontrolstudyandanupdatedmetaanalysisandmetaregression
AT senheetay endothelialdysfunctioninsystemiclupuserythematosusacasecontrolstudyandanupdatedmetaanalysisandmetaregression
AT lienghsiling endothelialdysfunctioninsystemiclupuserythematosusacasecontrolstudyandanupdatedmetaanalysisandmetaregression
_version_ 1718388600784027648